Oral GLP-1 agonist, Satiety Pathways, and Stem Cell tx for T1D
Jun 27, 2025•13 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Program notes:
0:40 Stem cells for type 1 diabetes
1:40 None had hypoglycemia afterwards
2:40 Autologous stem cells?
3:20 Oral GLP-1 agonist
4:20 Primary endpoint HbA1c reduction
5:20 Weight loss modest
6:20 Injectable GLP-1 plus an amylin analogue
7:20 Both those with diabetes and those without
8:20 No increased safety events
8:40 Mental health hospitalizations in adolescents
9:40 KID database
10:40 Females accounting for increase
11:40 67% of hospitalizations
12:57 End
For the best experience, listen in Metacast app for iOS or Android